Fresenius Medical Care AG (FME.DE)

38.67 +1.24 (+3.31%) 收市：05:35PM CEST

Fresenius Medical Care AG

Else-KrOener-Strasse 1
Bad Homburg 61352
Germany
49 6172 609 0
https://www.freseniusmedicalcare.com

版塊: Healthcare
行業: Medical Care Facilities
全職員工: 119,845

高階主管

名稱	頭銜	支付	行使價	出生年份
Ms. Helen Giza	CEO & Chair of Management Board of Fresenius Med. Care Mgmt AG	4.93M	無	1968
Mr. Martin Fischer	CFO & Member of the Management Board of Fresenius Medical Care Management AG	887k	無	1977
Dr. Franklin W. Maddux F.A.C.P.	Global Chief Medical Officer & Member of Management Board of Fresenius Medical Care Management AG	2.77M	無	1957
Dr. Katarzyna Mazur-Hofsab Ph.D.	Management Board Member for Care Enablement of Fresenius Medical Care Management AG	2.88M	無	1963
Mr. Craig Cordola FACHE, M.B.A., M.H.A.	CEO of Care Delivery & Member of Management Board	無	無	1969
Dr. Dominik Heger	Executive VP and Head of Investor Relations, Strategic Development & Communications	無	無	無
Mr. Joachim Weith	Senior Vice President of Corporate Communications & Governmental Affairs	無	無	無
Dr. Gail-Suzanne Brown	Senior Vice President of Research & Development	無	無	無
Mr. Glenn Slater	Senior Vice President of Manufacturing and Supply Chain Operations	無	無	無
Dr. Wolfgang Kummerle	Senior Vice President - Quality Management International	無	無	無

截止 2023年12月31日為止計算的金額，現金賠償則計算至上一個財政年度末止。薪資是指薪俸、獎金等。已行使價是指財政年度期間已行使的期權價值。貨幣為 EUR。

描述

Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, North America, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure. It also develops, manufactures, and distributes various health care products, including polysulfone dialyzers, hemodialysis machines, peritoneal dialysis cyclers, peritoneal dialysis solutions, hemodialysis concentrates, solutions and granulates, bloodlines, renal pharmaceuticals, systems for water treatment, and acute cardiopulmonary and apheresis products. In addition, the company develops, acquires, and in-licenses renal pharmaceuticals; offers renal medications and supplies to patients at homes or to dialysis clinics; and provides vascular, cardiovascular, endovascular specialty, vascular care ambulatory surgery center, and physician nephrology and cardiology services. The company sells its products to dialysis clinics, hospitals, and specialized treatment clinics directly, as well as through local sales forces, independent distributors, dealers, and sales agents. Fresenius Medical Care AG was incorporated in 1996 and is headquartered in Bad Homburg, Germany.

公司管治

截至 2024年5月1日 止，Fresenius Medical Care AG 的 ISS 管治質素評分為 4。 Pillar 分數正在審核中：7；董事會：5；股東權利：1；現金賠償：3。

企業管治評分的資料提供： Institutional Shareholder Services (ISS). 評分將以 1 至 10 分顯示 (與指數或地區相關)。1 分表示較低的管治風險，而 10 分表示較高的管治風險。